Viewing Study NCT04184518

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:58 AM
Ignite Modification Date: 2026-06-26 @ 2:53 PM
Study NCT ID: NCT04184518
Status: WITHDRAWN
Last Update Posted: 2020-06-02
First Post: 2019-11-29
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Durvalumab (MEDI4736) Plus Cediranib in Patients With Metastatic Uveal Melanoma
Sponsor: Grupo Español Multidisciplinar de Melanoma
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Uveal Melanoma View
None Metastatic Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None uveal melanoma View
None cediranib View
None durvalumab View
None liver metastasis View